9 Meters Biopharma Inc (NMTR)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
outlays have been growing at the NMTR in the financial interval closing December 31 2022
NMTR announced fourth quarter of 2022 operating deficit of $-10.741396 millions
Published Mar 29 2023
CSIMarket Team / CSIMarket.com
Trailing the bellwethers in the Major Pharmaceutical Preparations industry, a number of overlooked companies are reporting their results. NMTR told it has booked operating loss of $-10.741396 millions, for the fourth quarter of 2022.
The operating loss has worsened from $-9.564698 millions, from the fourth quarter of 2021. But more importantly, the market observers are guessing, when the NMTRs' will start to cite the revenue.
It is not really a surprise, that the rising firm recorded a net deficit of $-11.930 millions, which has swelled from $-9.555 millions, in the same time-frame a year before.
the Major Pharmaceutical Preparations company announced loss of $-43.77 millions and Revenues of $0.00 millions in the financial period 2022.
Net loss per share has widen to $-3.38 from $-0.15 in previous financial year, while by 0 % from $0.00 millions a year prior.
9 Meters Biopharma Inc is expected to report next financial results on May 15, 2023.
The operating loss has worsened from $-9.564698 millions, from the fourth quarter of 2021. But more importantly, the market observers are guessing, when the NMTRs' will start to cite the revenue.
It is not really a surprise, that the rising firm recorded a net deficit of $-11.930 millions, which has swelled from $-9.555 millions, in the same time-frame a year before.
the Major Pharmaceutical Preparations company announced loss of $-43.77 millions and Revenues of $0.00 millions in the financial period 2022.
Net loss per share has widen to $-3.38 from $-0.15 in previous financial year, while by 0 % from $0.00 millions a year prior.
9 Meters Biopharma Inc is expected to report next financial results on May 15, 2023.